-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Sigilon Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2022.
- Sigilon Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2023 was $1.56M, a 9.94% decline year-over-year.
- Sigilon Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2023 was $5.46M, a 6.01% decline year-over-year.
- Sigilon Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5.9M, a 4.05% decline from 2021.
- Sigilon Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $6.15M, a 96.7% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)